Researchers in areas such as tumor biology, immunology and pharmacology as well as pharma and biotech companies will use the imaging systems. Since its foundation, the company participated successfully in several competitions.
Overview
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 5, 2017 | Meet the startups participating in Hardware Battlefield 2017 at CES | We are thrilled to introduce the participants in the Hardware Battlefield 2017. These startups represent what we at TechCrunch feel are the most interesting, most promising early-stage hardware companies being built. Whether medical devices... |
| Jan 5, 2017 | Venneos launches a device for faster, better imaging of individual cells in biotech | The imaging technologies used in the medical and biotech fields may be powerful and indispensable for research and diagnosis, but they can also be slow and clumsy — relics of techniques that go back decades. Venneos wants to change that wit... |
| Sep 11, 2015 | Venneos Raises €1M in Seed Funding | Venneos GmbH, a Stuttgart, Germany-based developer of a novel imaging system for the analysis of biological cells, raised €1m in seed funding. Backers included a consortium of business angels and family offices, along with the High-Tech Grü... |
Reviews 0
FAQ about Venneos
How much funding has Venneos raised?
Venneos has raised $1.13M in total across 1 funding round.
What has the press written about Venneos?
Parsers VC has collected 4 articles mentioning Venneos, among them “Meet the startups participating in Hardware Battlefield 2017 at CES” (Jan 5, 2017) and “Venneos launches a device for faster, better imaging of individual cells in biotech” (Jan 5, 2017).
Is Venneos still active?
Venneos is probably closed: its latest activity on Parsers VC dates from Sep 26, 2017.